Italia markets open in 5 hours 59 minutes

Stereotaxis, Inc. (STXS)

NYSE American - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
2,3800-0,1800 (-7,03%)
Alla chiusura: 04:00PM EDT
2,4500 +0,07 (+2,94%)
Dopo ore: 06:28PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente2,5600
Aperto2,6100
Denaro2,3300 x 900
Lettera2,8200 x 1000
Min-Max giorno2,3800 - 2,6100
Intervallo di 52 settimane1,3300 - 3,2900
Volume238.204
Media Volume309.156
Capitalizzazione195,467M
Beta (5 anni mensile)1,34
Rapporto PE (ttm)N/D
EPS (ttm)-0,2700
Prossima data utili13 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A4,60
  • GlobeNewswire

    Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation

    ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s 7th Annual Meeting, which will take place October 19-20 in Washington, DC. The global physician-led Society for Cardiac Robotic Navigation (SCRN) is dedicated to establishing a community and platform for users of robotic technologies in card

  • GlobeNewswire

    Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology

    ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis Robotic Magnetic Navigation System. The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders. Rigs

  • GlobeNewswire

    Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment

    ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Overland Park Regional Medical Center (OPRMC) launched and successfully completed the first procedures using the advanced Genesis Robotic Magnetic Navigation (RMN) System. OPRMC – part of HCA Midwest Health, Kansas City’s largest healthcare provider – is the only hospital in the U.S. to offer t